TARGETING THE WNT PATHWAY TO REPROGRAM THE TUMOR MICROENVIRONMENT AND IMPROVE IMMUNOTHERAPY OF GBM

$276,197FY2019Department of the ArmyDOD

The General Hospital Corporation

Investigators